SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2022February06Sunday

With CRISPR gene editing, unique treatments begin to take off for rare diseases - The Washington Post

CRISPR activation and interference screens decode stimulation responses in primary human T cells - Science Magazine

CRISPR-Cas9 can generate unexpected, heritable mutations - Science Daily

New CRISPR patent hearing continues high-stakes legal battle - Science

Searching for CRISPR 2.0, Intellia spends $45M cash on an unknown Berkeley spinout - Endpoints News

Jennifer Doudna: What does CRISPR mean for the future of human evolution? - NPR

Global CRISPR Market & Competition Landscape 2021-2028 - GlobeNewswire

CRISPR, ViaCyte dose first subject in Phase I diabetes trial - Clinical Trials Arena

Could Crispr Flip the Switch on Insects' Resistance to Pesticides? - WIRED

Crispr Therapeutics' Giant Leap For Humankind - Seeking Alpha

Genetic Engineering: 2022February06Sunday

Nitrogen-Fixing Bacteria Are the Latest Genetic Engineering Breakthrough - The European Scientist

Could genetic engineering reverse insecticide resistance? - The Indian Express

The genetic engineering behind pig-to-human transplants - Ars Technica

Biomedical sciences student works toward a future in genetic engineering - UMass Medical School

How CRISPR and other forms of genetic engineering are revolutionizing farming and addressing climate change - Genetic Literacy Project

Nanotechnology strategies for plant genetic engineering - Nanowerk

The Plan to Put Bitcoin in Mouse DNA With a Genetically Engineered Virus - VICE

Food product labels - what do they mean? | St. Lawrence County | nny360.com - NNY360

Ryan Phelan: How gene technology can save species on the brink of extinction - NPR

(New Report) Genome Editing and Genome Engineering Market In 2022 : The Increasing use in Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering is driving the growth of the Industry across the globe – The Tech Talk - The Tech Talk

Gene Editing : 2022February06Sunday

With CRISPR gene editing, unique treatments begin to take off for rare diseases - The Washington Post

Intellia, expanding in gene editing, buys startup Rewrite for $45M - BioPharma Dive

Gene Editing Startup Metagenomi Raises $175 Million - BioPharm International

Novel DNA-free virus-like particles deliver gene-editing proteins to animal models - Drug Target Review

Sarepta reveals gene editing alliance with biotech exploring alternative delivery methods - BioPharma Dive

UK moves closer to allowing gene editing of crops by allowing more research - The Guardian

Pfizer buys into next-generation gene editing in $300 million deal with Beam Therapeutics - Chemical & Engineering News

List: Top CRISPR and Gene-Editing Biotechs to Know in 2022 - Business Insider

Other Barks & Bites for Friday, February 4: CRISPR Gene Editing Tech Debated at PTAB, PhRMA Calls Out 'Deeply Concerning' TRIPS Waiver to USTR, Deadline Closes for Comments on SEP Draft Policy Statement - IPWatchdog.com

Global CRISPR Gene Editing Market Report 2021-2031: - GlobeNewswire

CRISPR Therapy : 2022February06Sunday

With CRISPR gene editing, unique treatments begin to take off for rare diseases - The Washington Post

ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes - diaTribe

Dr. Kiana Aran receives NIH funding to help set Quality Control standards for CRISPR therapies - BioSpace

The Best CRISPR Companies to Invest In - Motley Fool

Intellia Broadens CRISPR Capabilities with Pick Up of Rewrite Therapeutics - BioSpace

Bayer Strikes "Mammoth" CRISPR Deal to Bolster Cell and Gene Therapy - BioSpace

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech - FierceBiotech

New Virus-Like Particles Can Deliver CRISPR to Any Cell in the Body - Singularity Hub

Pfizer, Beam Therapeutics Partner to Develop Treatments for 3 Genetic Diseases - Barron's

New drug combo identified for liver cancer via CRISPR-Cas9 screen - Science Daily